Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK050238-01A1
Application #
2017044
Study Section
Endocrinology Study Section (END)
Project Start
1996-09-20
Project End
2001-06-30
Budget Start
1996-09-20
Budget End
1997-06-30
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Cedars-Sinai Medical Center
Department
Type
DUNS #
075307785
City
Los Angeles
State
CA
Country
United States
Zip Code
90048
Bousquet, C; Chesnokova, V; Kariagina, A et al. (2001) cAMP neuropeptide agonists induce pituitary suppressor of cytokine signaling-3: novel negative feedback mechanism for corticotroph cytokine action. Mol Endocrinol 15:1880-90
Bousquet, C; Zatelli, M C; Melmed, S (2000) Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing. J Clin Invest 106:1417-25
Auernhammer, C J; Melmed, S (2000) Leukemia-inhibitory factor-neuroimmune modulator of endocrine function. Endocr Rev 21:313-45
Auernhammer, C J; Melmed, S (1999) Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis. Endocrinology 140:1559-66
Auernhammer, C J; Bousquet, C; Melmed, S (1999) Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. Proc Natl Acad Sci U S A 96:6964-9
Zhang, X; Horwitz, G A; Prezant, T R et al. (1999) Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). Mol Endocrinol 13:156-66
Gadelha, M R; Prezant, T R; Une, K N et al. (1999) Loss of heterozygosity on chromosome 11q13 in two families with acromegaly/gigantism is independent of mutations of the multiple endocrine neoplasia type I gene. J Clin Endocrinol Metab 84:249-56
Zhang, X; Horwitz, G A; Heaney, A P et al. (1999) Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab 84:761-7
Bousquet, C; Susini, C; Melmed, S (1999) Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor. J Clin Invest 104:1277-85
Shimon, I; Yan, X; Magoffin, D A et al. (1998) Intact leptin receptor is selectively expressed in human fetal pituitary and pituitary adenomas and signals human fetal pituitary growth hormone secretion. J Clin Endocrinol Metab 83:4059-64

Showing the most recent 10 out of 27 publications